tiprankstipranks
Trending News
More News >
Sanara MedTech (SMTI)
NASDAQ:SMTI
US Market

Sanara MedTech (SMTI) Earnings Dates, Call Summary & Reports

Compare
34 Followers

Earnings Data

Report Date
Aug 18, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
-0.44
Last Year’s EPS
-0.41
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Earnings Call Date:May 14, 2025
|
% Change Since: -17.38%
|
Next Earnings Date:Aug 18, 2025
Earnings Call Sentiment|Neutral
The earnings call reflects a strong performance in revenue growth, particularly in the Sanara Surgical segment, with significant improvements in gross margins and adjusted EBITDA. However, the company faced challenges such as increased net loss and operating expenses, as well as higher debt obligations and interest expenses. While there are significant positive strides, particularly in product sales and distributor expansion, the financial challenges balance the overall outlook.
Company Guidance
During the first quarter of 2025 earnings call, Sanara MedTech reported a net revenue of $23.4 million for its Sanara Surgical team, marking a 26% increase year-over-year. The company's growth was largely driven by a 28% rise in sales of its soft tissue repair products, totaling $20.5 million. Sales of bone fusion products also grew by 18% to $2.9 million. Despite a net loss for the Sanara Surgical Segment that increased by $200,000 to $600,000, adjusted EBITDA rose by $1.5 million to $2.7 million. Gross margins were enhanced, with gross profit increasing by 30% to $21.6 million, and the gross margin improved by approximately 240 basis points to 92% of net revenue. Operating expenses rose by 30% to $23.7 million, primarily due to a 32% increase in selling, general, and administrative expenses. The company also focused on expanding its distributor network, securing agreements with over 400 distributor partners, and increasing penetration in existing healthcare facilities. The Tissue Health Plus segment invested in developing a value-based wound care strategy and prepared to launch its pilot program in the second quarter. As of March 31, 2025, Sanara MedTech held $20.7 million in cash and $42.8 million in principal debt obligations, with $12.25 million of available borrowing capacity.
Sanara Surgical Revenue Growth
Sanara Surgical delivered net revenue of $23.4 million, representing 26% growth year-over-year, driven by a 28% increase in soft tissue repair product sales.
Strong Performance in Product Sales
Sales of CellerateRX Surgical and BIASURGE products fueled performance, and bone fusion products also saw an 18% increase year-over-year.
Enhanced Gross Margins
Gross profit increased by $5 million to $21.6 million, with a gross margin increase of approximately 240 basis points to 92% of net revenue.
Adjusted EBITDA Improvement
Sanara Surgical Segment adjusted EBITDA increased by $1.5 million year-over-year to $2.7 million.
Expansion of Distributor Network
Distributor network expanded to over 400 partners, up from over 250 in Q1 2024, providing increased sales coverage.
Tissue Health Plus Technology Platform Release
The first release of THP's technology platform, including the THP CoPilot app, was announced on May 1st, marking a pivotal milestone in wound care.

Sanara MedTech (SMTI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SMTI Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 18, 2025
2025 (Q2)
-0.44 / -
-0.41
May 14, 2025
2025 (Q1)
-0.51 / -0.41
-0.21-95.24% (-0.20)
Mar 25, 2025
2024 (Q4)
-0.12 / -0.18
-0.03-500.00% (-0.15)
Nov 12, 2024
2024 (Q3)
-0.62 / -0.34
-0.13-161.54% (-0.21)
Aug 12, 2024
2024 (Q2)
-0.21 / -0.41
-0.22-86.36% (-0.19)
May 13, 2024
2024 (Q1)
-0.07 / -0.21
-0.14-50.00% (-0.07)
Mar 25, 2024
2023 (Q4)
-0.13 / -0.03
-0.01-200.00% (-0.02)
Nov 13, 2023
2023 (Q3)
0.00 / -0.13
-0.1827.78% (+0.05)
Aug 14, 2023
2023 (Q2)
-0.13 / -0.22
-0.4247.62% (+0.20)
May 15, 2023
2023 (Q1)
-0.33 / -0.14
-0.4165.85% (+0.27)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SMTI Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 14, 2025
$35.10$31.30-10.83%
Mar 25, 2025
$35.69$31.20-12.58%
Nov 12, 2024
$34.60$37.22+7.57%
Aug 12, 2024
$27.83$32.04+15.13%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sanara MedTech (SMTI) report earnings?
Sanara MedTech (SMTI) is schdueled to report earning on Aug 18, 2025, TBA Not Confirmed.
    What is Sanara MedTech (SMTI) earnings time?
    Sanara MedTech (SMTI) earnings time is at Aug 18, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SMTI EPS forecast?
          SMTI EPS forecast for the fiscal quarter 2025 (Q2) is -0.44.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis